Simon Barry J.

CIK 00016479943 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001647994

Recent Transactions

50 trades

Sale
ImmunityBio, Inc.$IBRX
Common Stock
2026-02-24$12.01/sh−75,000→ 2,850,821 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2026-02-23$10.25/sh−165,000→ 2,925,821 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2026-02-22+15,243→ 3,096,847 total
Tax Payment
ImmunityBio, Inc.$IBRX
Common Stock
2026-02-22$8.70/sh−6,026→ 3,090,821 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Restricted Stock Units
2026-02-22−15,243→ 15,245 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2026-02-20$9.25/sh−10,000→ 3,081,604 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2026-01-20$7.88/sh−75,000→ 3,091,604 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2026-01-20$6.54/sh−76,967→ 3,166,604 total
Tax Payment
ImmunityBio, Inc.$IBRX
Common Stock
2025-02-22$3.42/sh−5,453→ 3,243,571 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Restricted Stock Units
2025-02-22−15,243→ 30,488 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2025-02-22+15,243→ 3,249,024 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2025-01-22−110,020→ 0 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2025-01-22$2.00/sh+110,020→ 3,233,781 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2024-06-20+50,000→ 50,000 total
Award
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2024-02-22+159,146→ 159,146 total
Award
ImmunityBio, Inc.$IBRX
Restricted Stock Units
2024-02-22+45,731→ 45,731 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2024-01-31+57,200→ 3,145,855 total
Tax Payment
ImmunityBio, Inc.$IBRX
Common Stock
2024-01-31$3.36/sh−22,094→ 3,123,761 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Restricted Stock Units
2024-01-31−57,200→ 0 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Restricted Stock Units
2023-09-01−57,199→ 57,200 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2023-09-01+57,199→ 3,088,655 total
Award
ImmunityBio, Inc.$IBRX
Restricted Stock Units
2023-08-25+114,399→ 114,399 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2023-06-08+40,000→ 40,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2022-06-09+40,000→ 40,000 total
Award
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2022-03-23+10,714→ 10,714 total
Gift
ImmunityBio, Inc.$IBRX
Common Stock
2021-06-04−71,051→ 3,031,456 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2021-05-25$16.18/sh−88,787→ 3,102,507 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2021-05-24$16.02/sh−21,223→ 3,191,294 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2021-05-21$16.09/sh−14,990→ 3,212,517 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2021-05-05$1.75/sh+56,967→ 3,227,507 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2021-05-05−56,967→ 0 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2021-03-26+80,000→ 80,000 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2021-02-05$2.00/sh+22,100→ 3,192,640 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2021-02-05$23.09/sh−22,100→ 3,170,540 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2021-02-05−22,100→ 110,020 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2021-02-02−82,070→ 132,120 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2021-02-02$20.65/sh−82,070→ 3,170,540 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2021-02-02$2.00/sh+82,070→ 3,252,610 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2021-01-28$2.00/sh+11,304→ 3,181,844 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2021-01-28−11,304→ 214,190 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2021-01-28$20.53/sh−11,304→ 3,170,540 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2021-01-27$20.61/sh−36,626→ 3,170,540 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2021-01-27−36,626→ 225,494 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2021-01-27$2.00/sh+36,626→ 3,207,166 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2021-01-04+10,000→ 10,000 total
Sale
ImmunityBio, Inc.$IBRX
Common Stock
2020-12-22$18.05/sh−130,000→ 3,170,540 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2020-12-22−130,000→ 262,120 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2020-12-22$2.00/sh+130,000→ 3,300,540 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Common Stock
2020-07-21$2.00/sh+1,565→ 3,172,105 total
Exercise/Conversion
ImmunityBio, Inc.$IBRX
Stock Option (right to buy)
2020-07-21−1,565→ 392,120 total

Companies

Recent Filings

Address

C/O IMMUNITYBIO, INC. 3530 JOHN HOPKINS COURT

SAN DIEGO, CA, 92121

View on SEC.gov